Title Serum levels of cytokines in infants treated with conbercept for retinopathy of prematurity
Authors Cheng, Yong
Zhu, Xuemei
Linghu, Dandan
Xu, Yongsheng
Liang, Jianhong
Affiliation Peking Univ, Dept Ophthalmol, Eye Dis & Optometry Inst,Beijing Key Lab Diag & T, Coll Optometry,Hlth Sci Ctr,Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R China
Peking Univ Peoples Hosp, Clin Ctr Optometry, Eye Dis & Optometry Inst,Beijing Key Lab Diag & T, Coll Optometry,Peking Univ Hlth Sci Ctr, 11 Xizhimen South St, Beijing 100044, Peoples R China
Peking Univ, Clin Stem Cell Res Ctr, Hosp 3, 49 Huayuan North Rd, Beijing, Peoples R China
Keywords ENDOTHELIAL GROWTH-FACTOR
INTRAVITREAL INJECTION
BEVACIZUMAB INJECTION
CORD BLOOD
VEGF
RANIBIZUMAB
EXPRESSION
PLASMA
PHARMACOKINETICS
PROTECTS
Issue Date 29-Jul-2020
Publisher SCIENTIFIC REPORTS
Abstract Intravitreal anti-vascular endothelial growth factor (VEGF) agents have revolutionized the treatment of retinopathy of prematurity (ROP); however, there are concerns regarding the potential systemic complications caused by those treatments. This study aimed to determine the serum concentrations of cytokines in infants with ROP and to evaluate the changes in serum VEGF concentrations after intravitreal conbercept (IVC). Sixty infants with ROP treated with IVC 0.25 mg were included. Blood samples were collected before treatment as well as 1 week and 4 weeks after treatment. Serum levels of 45 types of cytokines were measured by a multiplex bead assay. We observed that IVC 0.25 mg in ROP patients suppressed the circulating levels of VEGF-A and VEGF-D as of 1 week after injection, and these growth factor levels returned to baseline at 4 weeks. No significant differences were observed in the serum levels of the other cytokines between baseline and 1 or 4 weeks after IVC.
URI http://hdl.handle.net/20.500.11897/590862
ISSN 2045-2322
DOI 10.1038/s41598-020-69684-7
Indexed SCI(E)
Appears in Collections: 人民医院
第三医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.